FIP1L1-PDGFRA fusion
|
Chronic Eosinophilic Leukemia
|
FIP1L1-PDGFRA fusion
|
Chronic Eosinophilic Leukemia
|
imatinib Sensitive: A1 - Approval
|
imatinib Sensitive: A1 - Approval
|
FIP1L1-PDGFRA fusion
|
Sarcoma
|
FIP1L1-PDGFRA fusion
|
Sarcoma
|
imatinib Sensitive: C4 – Case Studies
|
imatinib Sensitive: C4 – Case Studies
|
FIP1L1-PDGFRA fusion
|
Chronic Eosinophilic Leukemia
|
FIP1L1-PDGFRA fusion
|
Chronic Eosinophilic Leukemia
|
YD312 Sensitive: C4 – Case Studies
|
YD312 Sensitive: C4 – Case Studies
|
FIP1L1-PDGFRA fusion
|
AML
|
FIP1L1-PDGFRA fusion
|
AML
|
ponatinib Sensitive: D – Preclinical
|
ponatinib Sensitive: D – Preclinical
|